Phosphoproteome Profiling of the Receptor Tyrosine Kinase MuSK Identifies Tyrosine Phosphorylation of Rab GTPases

Muscle-specific receptor tyrosine kinase (MuSK) agonist antibodies were developed 2 decades ago to explore the benefits of receptor activation at the neuromuscular junction. Unlike agrin, the endogenous agonist of MuSK, agonist antibodies function independently of its coreceptor low-density lipoprotein receptor–related protein 4 to delay the onset of muscle denervation in mouse models of ALS. Here, we performed dose–response and time-course experiments on myotubes to systematically compare site-specific phosphorylation downstream of each agonist. Remarkably, both agonists elicited similar intracellular responses at known and newly identified MuSK signaling components. Among these was inducible tyrosine phosphorylation of multiple Rab GTPases that was blocked by MuSK inhibition. Importantly, mutation of this site in Rab10 disrupts association with its effector proteins, molecule interacting with CasL 1/3. Together, these data provide in-depth characterization of MuSK signaling, describe two novel MuSK inhibitors, and expose phosphorylation of Rab GTPases downstream of receptor tyrosine kinase activation in myotubes.     

Comparative Network Biology Discovers Protein Complexes That Underline Cellular Differentiation in Anabaena sp.

The filamentous cyanobacterium Anabaena sp. PCC 7120 can differentiate into heterocysts to fix atmospheric nitrogen. During cell differentiation, cellular morphology and gene expression undergo a series of significant changes. To uncover the mechanisms responsible for these alterations, we built protein–protein interaction (PPI) networks for these two cell types by cofractionation coupled with mass spectrometry. We predicted 280 and 215 protein complexes, with 6322 and 2791 high-confidence PPIs in vegetative cells and heterocysts, respectively. Most of the proteins in both types of cells presented similar elution profiles, whereas the elution peaks of 438 proteins showed significant changes. We observed that some well-known complexes recruited new members in heterocysts, such as ribosomes, diflavin flavoprotein, and cytochrome c oxidase. Photosynthetic complexes, including photosystem I, photosystem II, and phycobilisome, remained in both vegetative cells and heterocysts for electron transfer and energy generation. Besides that, PPI data also reveal new functions of proteins. For example, the hypothetical protein Alr4359 was found to interact with FraH and Alr4119 in heterocysts and was located on heterocyst poles, thereby influencing the diazotrophic growth of filaments. The overexpression of Alr4359 suspended heterocyst formation and altered the pigment composition and filament length. This work demonstrates the differences in protein assemblies and provides insight into physiological regulation during cell differentiation.     

迟眼蕈蚊抗菌肽BhSGAMP-1-S在大肠杆菌中的优化表达及其活性分析(英文)

【目的】BhSGAMP-1 是迟眼蕈蚊唾液腺抗菌肽,为了能够更好的了解其分子特性,我们将其表达、纯化并进行了活性测定。【方法】依据大肠杆菌稀有密码子设计并合成了抗菌肽基因 BhSGAMP-1-S,以 pMAL-c2X 作为表达载体在大肠杆菌 TB1 中进行融合表达,融合蛋白通过麦芽糖亲和层析柱进行纯化,获得的融合蛋白经肠激酶切割后,混合物通过分子筛凝胶层析和反相高效液相色谱来获得单体重组抗菌肽 BhSGAMP-1-S,对获得的抗菌肽进行活性测定。【结果】在最优的表达条件下融合蛋白以可溶的形式表达,100 mL 诱导菌液经多步纯化后可得 0. 38 mg 的重组抗菌肽 BhSGAMP-1-S,抑菌活性测定表明所获得的抗菌肽对部分测试革兰氏阳性细菌、革兰氏阴性细菌和真菌有较强的抑菌活性。【结论】本研究第一次成功的在大肠杆菌中诱导表达了修饰合成的抗菌肽 BhSGAMP-1-S,纯化后的抗菌肽具有很好的抑菌活性,这为进一步研究和应用奠定了基础。     

人Leptin基因在大肠杆菌中的高效表达、纯化及其生物学活性研究

将人Leptin表达质粒pBV220-OB转化E.coliJM109,经热诱导获得了目的蛋白的表达。经SDS-PAGE鉴定分析,表达产物以包涵体形式存在,目的蛋白表达量占菌体总蛋白的40%以上。通过包涵体分离,Sephacryl S200HR凝胶和DEAE52离子交换层析及Hypersil C18柱反相色谱纯化,获得纯度在95%以上,内毒素含量小于10EU/mg的高纯度的重组人Leptin。Western-blot鉴定表明,纯化表达产物能和抗Leptin抗体特异性结合;蛋白质N端15个氨基酸序列分析结果和预期的序列一致。纯化产物经复性处理,其分子中Cys96和Cys146形成二硫键。体内活性检测显示,纯化和复性的rh-Leptin明显抑制BALB/c小鼠的进食和体重增长,提示其具有明显的生物学活性。     

灰绿曲霉β-葡萄糖苷酶的分离及特性

目的：利用灰绿曲霉EU7-22发酵产纤维素酶,从中分离到β-葡萄糖苷酶,分析其理化特性,确定其最佳活性条件。方法：灰绿曲霉EU7-22发酵液离心后,上清液经硫酸铵沉淀、Phenyl 6 Fast Flow（highsub）疏水层析和Sephacryl S-200凝胶层析,获得纯化的β-葡萄糖苷酶。结果：纯酶的比活性为5.1 IU/mg,得率为13.89%。SDS-PAGE凝胶电泳分析表明该酶是单亚基蛋白,其分子量为56.2 kDa。在pH4.0~6.0范围内,β-葡萄糖苷酶具有较高的稳定性,该酶的最适酶促反应pH为5.0。当β-葡萄糖苷酶在温度低于60℃的缓冲液中温育1 h后,酶活损失不大,表现了较好的稳定性;当该酶在温度高于60℃的缓冲液中温育1 h后,酶活迅速丧失。β-葡萄糖苷酶在70℃时具有最大催化活性。结论：灰绿曲霉EU7-22发酵产生的β-葡萄糖苷酶具有较高活性,具有分子量较小、最佳催化温度较高的特点。     

人松弛素原样蛋白H2在大肠杆菌中的表达、分离纯化及鉴定

利用聚合酶链式反应方法 ,从含有人前松弛素原cDNA基因的质粒 pMALp2X-hRLXH2上得到人松弛素原H2的编码基因 ,亚克隆到温度诱导型原核表达载体pBV2 2 0上 ,转化大肠杆菌DH5α细胞。经 4 2℃温度诱导 ,获得了目的基因的高效表达。目的蛋白质以包含体的形式存在于大肠杆菌细胞中。菌体经过超声波破碎 ,包含体裂解 ,蛋白质的体外变性还原 ,复性 ,SephadexG 75凝胶过滤层析 ,反相快速蛋白质液相层析等一系列分离纯化过程 ,得到了高纯度的重组Met 人松弛素原样蛋白H2 ,得率约为 2～ 3mg/L。对纯化的目的蛋白质进行了SDS PAGE电泳纯度分析 ,氨基酸组成分析 ,通过基质辅助激光解吸电离飞行时间质谱法测得目的蛋白质的分子量为 183 90 .4 (理论计算值为 183 92 .3 )。     

人纤溶酶原K1-3基因的克隆、表达和产物的纯化及抗癌活性分析

纤溶酶原K1－3功能区是近年发现的血管生成抑制因子,具有抑制肿瘤生长和转移的活性。以人血管生成抑制素cDNA为模板用PCR技术扩增了K1－3功能区的基因,DNA序列分析后克隆至质粒pPIC9上获得重组质粒pPIC9K13转化毕节酵母GS115,用PCR和G418法筛选高拷贝转化子,进行摇瓶发酵。SDS－PAGE和Western blot分析结果证实K1－3基因已在GS115分泌表达,并具有免疫活性。选用30L和80L罐进行高密度发酵,甲醇诱导48h细胞密度达到OD250－300,比摇瓶提高5－6倍,表达量150－200mg/L,发酵上清液经Streamline SP离子交换及Phenyl-Sephorose疏水层析纯化,在SDS－PAGE上显示一条带,纯度96％,动物实验证明纯化产物具有抗血管生成和抗肿瘤的活性。     

蛋白激酶D1催化结构域在昆虫细胞/杆状病毒表达系统内的表达、纯化和活性测定

蛋白激酶D(Protein kinase D,PKD)是一种新的丝氨酸/苏氨酸蛋白激酶家族和甘油二酯(Diacylglycerol,DAG)受体,参与细胞内多种生理生化过程。为获得高纯度的PKD1的催化结构域(PKD1-cat)用于晶体学结构的研究,将带有GST标签的PKD1-cat基因克隆到杆状病毒转移载体pFastBac1中,构建了重组质粒。将重组质粒转化到含穿梭载体Bacmid的DH10Bac感受态细胞中,转座后获得了含目的基因GST-PKD1-cat的重组Bacmid。重组Bacmid DNA转染Sf9昆虫细胞后,获得重组杆状病毒并扩毒。将毒种以5 PFU/cell的感染复数感染悬浮培养的T.ni昆虫细胞,SDS-PAGE和Western blotting检测表达产物。结果显示,表达产物在分子量约68 kDa处有一特异条带可与GST单克隆抗体发生反应。经谷胱甘肽琼脂糖凝胶亲和层析纯化和PreScission Protease切除GST标签后,得到了纯度很高的分子量约42 kDa的目的蛋白PKD1-cat。体外PKD激酶活性实验结果显示,随着PKD1-cat浓度的增加,激酶活性增高。这些结果显示截短的重组PKD1-cat有很高的催化活性和纯度,为采用核磁共振或晶体学方法解析PKD1-cat的三维结构奠定了基础。     

大孔树脂分离纯化“黑金刚”紫马铃薯花青苷工艺研究

以紫色马铃薯"黑金刚"花青苷为原料,采用D101、HDP100A、HDP450A、NK-9、AB-8五种大孔吸附树脂对花青苷的吸附与解析特性进行了比较研究,并在此基础上,采用最佳大孔树脂对花青苷纯化过程中的静态、动态吸附和解析附条件进行了优化研究。结果表明AB-8大孔树脂具有较好的吸附和解析能力,是纯化紫色马铃薯花青苷的最佳树脂,较优纯化条件为:上样液花青苷浓度为0.028mg.g-1,上样液pH=2,洗脱液乙醇浓度为50%,洗脱液pH=1,吸附流速为1mL.min-1,洗脱流速为1mL.min-1。经大孔树脂纯化后,色价值比纯化前提高了7.55倍。     

用壳聚糖亲和磁性微球纯化血浆凝血酶的研究

通过化学共沉淀法合成纳米粒子Fe3O4磁核,以壳聚糖为包裹材料包被自制的磁核,采用乳化交联法制备了具有核-壳结构的磁性高分子微球-壳聚糖磁性微球,并偶联肝素配基得到了一种新型亲和磁性微球,应用SEM、FT-IR、XRD等对微球的粒径、形貌、结构和磁响应性进行了表征.考察了该亲和磁性微球对凝血酶的分离纯化性能,并与传统的DEAE离子交换色谱法进行了比较.结果表明,所得亲和磁性微球具有较窄的粒径分布、形状规整,粒径在50nm左右.对凝血酶一步吸附纯化获得了比活为1879.71U/mg的酶,得率85%,纯化倍数11.057,而传统柱层析法得率为72%,纯化倍数仅为5.33.制备了壳聚糖亲和磁性微球,并将磁分离技术应用于凝血酶的分离纯化,得到了较好的效果,这将对于凝血酶的纯化及生产具有一定参考价值.